GMED Globus Medical, Inc. Class A Common Stock

NYSE · Health Care · Ver en SEC EDGAR ↗
$88,45
Precio · Ago 19, 2026
Fundamentales a fecha de Ago 6, 2026

Acerca de Globus Medical, Inc. Class A Common Stock Descripción general de la empresa de Wikipedia

Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.

Leer más

Globus Medical, Inc. is a publicly traded orthopedic medical device company headquartered in Audubon, Pennsylvania, United States. Globus is focused on the design, development, and commercialization of products that enable surgeons to promote healing in patients with musculoskeletal disorders.

Products

Globus develops, manufactures, and markets orthopedic implants including spine, trauma, and artificial joints.

Globus Medical makes the ExcelsiusGPS surgical robotic system for spine surgery. The robot is used for transpedicular drilling and screw placement. In November 2024, the company launched its ExcesiusHub, an advanced surgical navigation system for robotic surgical procedures.

The ADIRA XLIF Plate System aids in enhancing lateral spine surgery procedures.

Acquisitions

In January 2014, Globus Medical acquired Excelsius Surgical. The Excelsius system is designed to integrate intra-operative digital imaging with a robotic surgery device to hold patients in place during surgeries "with sub-millimeter accuracy". In October of that year, the company acquired allograft tissue processor Transplant Technologies of Texas, Ltd. (TTOT). TTOT provides human tissue products, including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets.

In February 2015, Globus Medical acquired Branch Medical Group, a third-party manufacturer of high-precision medical devices.

In July 2016, Globus Medical acquired Alphatec Holdings, an international operations and distribution channel, for $80 million. As part of the transaction, Globus has agreed to provide Alphatec a five-year senior secured credit facility of up to $30 million.

In September 2018, Globus Medical acquired Nemaris, developers of Surgimap, a pre-operative planning software for spinal surgeons.

In August 2019, Globus Medical acquired privately owned StelKast, manufacturer of implants and instruments for hip and knee replacement.

In February 2023, Globus Medical acquired NuVasive in an all-stock deal valued at $3.1 billion.

Controversies

In August 2007 Globus Medical settled a lawsuit initially filed by Synthes in 2004 over alleged stolen trade secrets. Former Synthes employees, who then worked for Globus, were accused of stealing 2300 electronic files containing blueprints for Synthes' products, safety-testing plans, and verbatim 510(k) filing documents. Globus paid Synthes $13.5 million and did not admit any wrongdoing.

In 2011, Synthes filed a second lawsuit against Globus Medical for infringing three patents, "asking the court to force the defendant to destroy its allegedly infringing products." Orthopedic Design & Technology Magazine reports that, "There was no finding of willful infringement in this lawsuit." A $16 million monetary damage was paid by Globus Medical in 2013.

Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗

Wikidata ↗

GMED Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

Precio
$88.45
Capitalización Bursátil
P/E (TTM)
22.3
BPA (TTM)
$3.92
Ingresos (TTM)
$2.94B
Rendimiento div.
ROE
12.1%
Deuda/Capital
Rango 52S
$54 – $101

GMED Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

Ingresos y Beneficio Neto $2.94B
10-point trend, +421.1%
2016-12-31 2025-12-31
BPA $3.92
10-point trend, +263.0%
2016-12-31 2025-12-31
Flujo de caja libre $589M
9-point trend, +349.5%
2016-12-31 2025-12-31
Márgenes 18.3%
7-point trend, -14.5%
2016-12-31 2023-12-31

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Métrica
Tendencia a 5 años
GMED
Mediana de Pares
P/E (TTM)
5-point trend, -55.6%
22.3
27.5

Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC

Métrica
Tendencia a 5 años
GMED
Mediana de Pares
Operating Margin (Margen Operativo)
5-point trend, +15.7%
16.3%
Net Profit Margin (Margen de Beneficio Neto)
5-point trend, +41.2%
18.3%
9.8%
ROA
5-point trend, +60.0%
10.2%
5.1%
ROE
5-point trend, +73.3%
12.1%
8.6%
ROIC
5-point trend, +55.2%
9.3%

Salud financiera Deuda, liquidez, solvencia — solidez del balance general

Métrica
Tendencia a 5 años
GMED
Mediana de Pares
Current Ratio (Ratio corriente)
5-point trend, -37.3%
4.3
2.7
Quick Ratio (Ratio Rápido)
5-point trend, +111.4%
2.5

Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años

Métrica
Tendencia a 5 años
GMED
Mediana de Pares
Revenue YoY (Ingresos interanuales)
5-point trend, +206.7%
16.7%
Revenue CAGR 3Y (Ingresos CAGR 3A)
5-point trend, +206.7%
42.2%
Revenue CAGR 5Y (Ingresos CAGR 5A)
5-point trend, +206.7%
30.1%
EPS YoY (EPS interanual)
5-point trend, +172.2%
422.7%
Net Income YoY (Beneficio Neto interanual)
5-point trend, +260.5%
422.3%

Métricas por acción BPA, valor contable por acción, flujo de caja por acción, dividendo por acción

Métrica
Tendencia a 5 años
GMED
Mediana de Pares
EPS (Diluted) (BPA (Diluido))
5-point trend, +172.2%
$3.92

Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar

Métrica
Tendencia a 5 años
GMED
Mediana de Pares

GMED Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

COMPRA 23 analistas
  • Compra fuerte 4 17,4%
  • Compra 12 52,2%
  • Mantener 7 30,4%
  • Venta 0 0,0%
  • Venta fuerte 0 0,0%

Precio objetivo a 12 meses

13 analistas · 2026-08-15
Objetivo mediano $100.00 +13,1%
Objetivo medio $103.23 +16,7%

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

Sorpresa Media
0.15%
Período EPS Actual EPS est. Sorpresa
30 de junio de 2026 $1.34 $1.12 0.22%
31 de marzo de 2026 $1.12 $0.94 0.18%
31 de diciembre de 2025 $1.28 $1.17 0.11%
30 de septiembre de 2025 $1.18 $0.80 0.38%
30 de junio de 2025 $0.86 $0.77 0.09%
31 de marzo de 2025 $0.68 $0.76 -0.08%

Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector

Ticker Capitalización Bursátil P/E Ingresos interanuales Margen Neto ROE Margen Bruto
GMED 22.3 16.7% 18.3% 12.1%
RMD $28.11B 18.7 9.8% 26.9% 23.6% 61.1%
ZBH $28.66B 25.3 7.2% 8.6% 5.6%
BAX $13.05B -10.2 5.7% -8.5% -14.6% 30.0%
PEN $12.20B 68.8 17.5% 12.7% 13.1% 67.1%
GKOS $6.49B -34.4 32.3% -37.0% -26.4% 55.7%
PODD $20.01B 81.7 30.7% 9.1% 16.6% 71.6%
TFX -6.0 17.2% -45.5% -24.6% 56.2%
NVST $3.56B 77.5 8.3% 1.7% 1.5% 54.7%
ITGR $2.69B 27.1 8.0% 5.5% 6.0% 27.0%
ABT $250.18B 33.7 5.7% 14.7% 13.1%

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

Estado de resultados 16
Datos anuales de Estado de resultados para GMED
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +519.5% $2.94B $2.52B $1.57B $1.02B $958M $789M $785M $713M $636M $564M $545M $474M
Cost of Revenue 12-point trend, +764.7% $958M $1.04B $548M $264M $239M $217M $180M $159M $150M $135M $132M $111M
Gross Profit 10-point trend, +180.6% · · $1.02B $759M $719M $572M $605M $554M $486M $429M $412M $364M
R&D Expense 12-point trend, +372.5% $147M $164M $124M $73M $97M $85M $60M $55M $44M $45M $36M $31M
SG&A Expense 12-point trend, +524.8% $1.18B $981M $644M $432M $408M $355M $355M $312M $268M $222M $210M $189M
Operating Expenses 10-point trend, +293.9% · · $887M $531M $547M $460M $433M $384M $324M $275M $240M $225M
Operating Income 12-point trend, +246.8% $480M $166M $133M $228M $172M $111M $172M $169M $162M $154M $172M $138M
Other Non-op 12-point trend, +1118.9% $3M $2M $-2M $2M $8M $14M $18M $19M $8M $3M $583.0K $280.0K
Pretax Income 12-point trend, +336.4% $605M $121M $165M $243M $180M $126M $190M $189M $170M $157M $173M $139M
Income Tax 12-point trend, +45.6% $67M $18M $43M $53M $31M $24M $35M $32M $63M $53M $60M $46M
Net Income 12-point trend, +481.6% $538M $103M $123M $190M $149M $102M $155M $156M $107M $104M $113M $92M
EPS (Basic) 12-point trend, +306.1% $3.98 $0.76 $1.09 $1.89 $1.48 $1.04 $1.57 $1.60 $1.12 $1.09 $1.19 $0.98
EPS (Diluted) 12-point trend, +304.1% $3.92 $0.75 $1.07 $1.85 $1.44 $1.01 $1.52 $1.54 $1.10 $1.08 $1.17 $0.97
Shares (Basic) 12-point trend, +43.5% 135,215,000 135,726,000 113,087,000 100,469,000 100,734,000 98,580,000 99,150,000 97,884,000 96,243,000 95,647,000 95,046,000 94,227,000
Shares (Diluted) 12-point trend, +43.6% 137,056,000 137,863,000 114,630,000 102,643,000 103,623,000 100,971,000 101,998,000 101,316,000 97,887,000 96,432,000 96,073,000 95,457,000
EBITDA 11-point trend, +372.6% $757M $420M $278M · $242M $174M $225M $211M $204M $193M $196M $160M
Balance general 26
Datos anuales de Balance general para GMED
Métrica Tendencia 202520242023202220212020201920182017201620152014
Cash & Equivalents 8-point trend, +539.6% $526M $784M · · · · $195M $140M $119M $67M $58M $82M
Short-term Investments 11-point trend, -78.8% $31M $106M $50M $296M $250M $187M · $200M $255M $223M $221M $146M
Receivables 12-point trend, +800.1% $679M $558M $503M $213M $164M $142M $154M $137M $117M $92M $78M $75M
Inventory 12-point trend, +734.9% $759M $659M $848M $299M $237M $229M $196M $131M $108M $113M $105M $91M
Prepaid Expense 12-point trend, +1039.4% $65M $50M $45M $21M $18M $18M $17M $15M $11M $15M $7M $6M
Current Assets 12-point trend, +352.2% $2.13B $2.18B $1.92B $983M $865M $822M $687M $631M $620M $514M $545M $470M
PP&E (Net) 12-point trend, +712.5% $564M $562M $587M $244M $221M $217M $200M $172M $143M $124M $115M $69M
PP&E (Gross) 12-point trend, +575.2% $1.27B $1.11B $1.01B $587M $527M $493M $444M $389M $335M $291M $254M $188M
Accum. Depreciation 12-point trend, +494.7% $705M $546M $426M $343M $306M $276M $244M $217M $192M $167M $139M $119M
Goodwill 12-point trend, +2597.6% $1.44B $1.43B $1.43B $197M $180M $157M $129M $124M $124M $106M $92M $53M
Intangibles 12-point trend, +2057.8% $745M $795M $925M $64M $69M $87M $79M $87M $79M $62M $33M $35M
Other Non-current Assets 12-point trend, +7980.1% $79M $75M $79M $37M $36M $32M $22M $10M $8M $928.0K $590.0K $975.0K
Total Assets 12-point trend, +653.7% $5.30B $5.25B $5.09B $2.08B $1.96B $1.68B $1.53B $1.30B $1.08B $928M $834M $704M
Accounts Payable 12-point trend, +521.6% $99M $75M $57M $36M $22M $18M $25M $26M $25M $17M $16M $16M
Accrued Liabilities 12-point trend, +442.4% $334M $261M $240M $92M $91M $78M $63M $60M $53M $46M $54M $61M
Current Liabilities 12-point trend, +457.5% $498M $856M $392M $159M $140M $121M $111M $96M $93M $80M $83M $89M
Capital Leases 7-point trend, +8999.6% $104M $84M $91M $3M $3M $3M $1M · · · · ·
Deferred Tax 11-point trend, +362.4% · $24M $84M $2M $4M $6M $6M $8M $11M $8M $13M $5M
Other Non-current Liabilities 12-point trend, +542.9% $21M $22M $25M $10M $13M $15M $9M $8M $2M $2M $2M $3M
Total Liabilities 12-point trend, +517.7% $730M $1.07B $1.09B $230M $216M $173M $130M $115M $111M $96M $119M $118M
Paid-in Capital 12-point trend, +1708.8% $3.17B $3.03B $2.87B $631M $554M $457M $357M $300M $238M $212M $193M $175M
Retained Earnings 12-point trend, +237.1% $1.39B $1.15B $1.14B $1.24B $1.19B $1.05B $1.05B $893M $736M $629M $525M $412M
AOCI 12-point trend, +1026.1% $15M $-7M $-10M $-25M $-7M $4M $-3M $-7M $-7M $-9M $-2M $-2M
Stockholders' Equity 12-point trend, +681.1% $4.57B $4.18B $4.00B $1.85B $1.74B $1.51B $1.40B $1.19B $968M $832M $715M $585M
Liabilities + Equity 12-point trend, +653.7% $5.30B $5.25B $5.09B $2.08B $1.96B $1.68B $1.53B $1.30B $1.08B $928M $834M $704M
Shares Outstanding 6-point trend, +5.4% · · · · · · 99,825,080 98,573,354 96,657,881 95,929,916 95,319,722 94,705,743
Flujo de Efectivo 16
Datos anuales de Flujo de Efectivo para GMED
Métrica Tendencia 202520242023202220212020201920182017201620152014
D&A 12-point trend, +1172.6% $277M $253M $146M $68M $70M $63M $53M $42M $42M $39M $24M $22M
Stock-based Comp 12-point trend, +600.0% $50M $54M $53M $33M $31M $27M $26M $22M $15M $11M $10M $7M
Deferred Tax 11-point trend, -3234.3% · $-134M $-58M $-22M $-18M $-4M $4M $971.0K $8M $-4M $6M $-4M
Amort. of Intangibles 12-point trend, +16500.3% $118M $119M $51M $18M $19M $17M $14M $10M $8M $3M $2M $712.0K
Restructuring · $30M · · · · · · · · · ·
Other Non-cash 11-point trend, -191.0% $-111M $243M $-19M · $44M $11M $-66M $-39M $-13M $22M $-31M $-38M
Operating Cash Flow 12-point trend, +851.7% $753M $521M $243M $178M $276M $199M $172M $182M $159M $148M $124M $79M
CapEx 12-point trend, +565.3% $165M $115M $78M $74M $57M $64M $71M $60M $51M $41M $51M $25M
Investing Cash Flow 12-point trend, -255.0% $-355M $-176M $303M $-110M $-376M $-117M $-140M $-193M $-111M $-163M $-153M $-100M
Stock Issued · · · · · · · · · · · $10M
Stock Repurchased 5-point trend, +187.0% $300M $86M $226M $144M · $105M · · · · · ·
Net Stock Activity 5-point trend, -3185.3% $-300M $-86M $-226M · · $-105M · · · · · $10M
Financing Cash Flow 12-point trend, -5346.1% $-679M $-28M $-232M $-110M $54M $-39M $24M $33M $2M $470.0K $4M $13M
Net Change in Cash 12-point trend, -3255.6% $-258M $317M $317M $-43M $-46M $44M $56M $21M $51M $-16M $-25M $-8M
Taxes Paid 8-point trend, +223.8% $99M $159M $101M $78M $45M $25M $34M $31M · · · ·
Free Cash Flow 11-point trend, +981.9% $589M $405M $165M · $219M $135M $101M $122M $108M $131M $71M $54M
Rentabilidad 8
Datos anuales de Rentabilidad para GMED
Métrica Tendencia 202520242023202220212020201920182017201620152014
Gross Margin 9-point trend, -15.1% · · 65.0% · 75.0% 72.4% 77.1% 77.6% 76.3% 76.1% 75.6% 76.6%
Operating Margin 11-point trend, -44.0% 16.3% 6.6% 8.5% · 17.9% 14.1% 21.9% 23.8% 25.4% 27.3% 31.6% 29.2%
Net Margin 11-point trend, -6.2% 18.3% 4.1% 7.8% · 15.6% 13.0% 19.8% 21.9% 16.9% 18.5% 20.7% 19.5%
Pretax Margin 11-point trend, -29.6% 20.6% 4.8% 10.5% · 18.8% 16.0% 24.2% 26.5% 26.7% 27.9% 31.7% 29.2%
EBITDA Margin 11-point trend, -23.7% 25.8% 16.7% 17.7% · 25.2% 22.1% 28.6% 29.6% 32.1% 34.2% 36.0% 33.8%
ROA 11-point trend, -30.1% 10.2% 2.0% 3.4% · 8.2% 6.4% 11.0% 13.2% 10.7% 11.8% 14.7% 14.6%
ROE 11-point trend, -30.6% 12.1% 2.5% 3.0% · 8.6% 7.0% 11.3% 13.5% 11.9% 13.5% 17.3% 17.5%
ROIC 11-point trend, -40.8% 9.3% 3.4% 2.5% · 8.2% 6.0% 10.0% 11.8% 10.6% 12.3% 15.7% 15.8%
Liquidez y Solvencia 2
Datos anuales de Liquidez y Solvencia para GMED
Métrica Tendencia 202520242023202220212020201920182017201620152014
Current Ratio 11-point trend, -18.9% 4.3 2.5 4.9 · 6.2 6.8 6.2 6.6 6.7 6.4 6.6 5.3
Quick Ratio 11-point trend, -27.1% 2.5 0.8 1.4 · 3.0 1.2 3.1 5.0 5.3 4.8 4.3 3.4
Eficiencia 3
Datos anuales de Eficiencia para GMED
Métrica Tendencia 202520242023202220212020201920182017201620152014
Asset Turnover 11-point trend, -25.5% 0.6 0.5 0.4 · 0.5 0.5 0.6 0.6 0.6 0.6 0.7 0.7
Inventory Turnover 11-point trend, -1.8% 1.4 1.4 1.0 · 1.0 1.0 1.1 1.3 1.4 1.2 1.4 1.4
Receivables Turnover 11-point trend, -30.9% 4.8 4.7 4.4 · 6.3 5.3 5.4 5.6 6.1 6.6 7.1 6.9
Por Acción 5
Datos anuales de Por Acción para GMED
Métrica Tendencia 202520242023202220212020201920182017201620152014
Book Value / Share 6-point trend, +127.3% · · · · · · $14.05 $12.03 $10.01 $8.67 $7.50 $6.18
Revenue / Share 11-point trend, +331.5% $21.44 $18.27 $13.68 · $9.25 $7.81 $7.70 $7.04 $6.50 $5.85 $5.67 $4.97
Cash Flow / Share 11-point trend, +562.8% $5.50 $3.78 $2.12 · $2.67 $1.97 $1.69 $1.79 $1.63 $1.78 $1.27 $0.83
Cash / Share 6-point trend, +125.4% · · · · · · $1.96 $1.42 $1.23 $1.38 $0.63 $0.87
EPS (TTM) 12-point trend, +304.1% $3.92 $0.75 $1.07 $1.85 $1.44 $1.01 $1.52 $1.54 $1.10 $1.08 $1.17 $0.97
Tasas de Crecimiento 9
Datos anuales de Tasas de Crecimiento para GMED
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -22.3% 16.7% 60.6% 53.3% 6.8% 21.4% · · · · · · ·
Revenue CAGR 3Y 3-point trend, +63.8% 42.2% 38.0% 25.7% · · · · · · · · ·
Revenue CAGR 5Y 30.1% · · · · · · · · · · ·
EPS YoY 5-point trend, +892.9% 422.7% -29.9% -42.2% 28.5% 42.6% · · · · · · ·
EPS CAGR 3Y 3-point trend, +1366.0% 28.4% -19.5% 1.9% · · · · · · · · ·
EPS CAGR 5Y 31.2% · · · · · · · · · · ·
Net Income YoY 5-point trend, +820.8% 422.3% -16.2% -35.4% 27.5% 45.9% · · · · · · ·
Net Income CAGR 3Y 3-point trend, +557.5% 41.4% -11.6% 6.3% · · · · · · · · ·
Net Income CAGR 5Y 39.4% · · · · · · · · · · ·
Valoración (TTM) 9
Datos anuales de Valoración (TTM) para GMED
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +519.5% $2.94B $2.52B $1.57B $1.02B $958M $789M $785M $713M $636M $564M $545M $474M
Net Income TTM 12-point trend, +481.6% $538M $103M $123M $190M $149M $102M $155M $156M $107M $104M $113M $92M
Market Cap 6-point trend, +161.1% · · · · · · $5.88B $4.27B $3.97B $2.38B $2.65B $2.25B
P/E 12-point trend, -9.1% 22.3 110.3 49.8 40.1 50.1 64.6 38.7 28.1 37.4 23.0 23.8 24.5
P/S 6-point trend, +57.7% · · · · · · 7.5 6.0 6.2 4.2 4.9 4.7
P/B 6-point trend, +9.0% · · · · · · 4.2 3.6 4.1 2.9 3.7 3.8
P / Cash Flow 6-point trend, +20.2% · · · · · · 34.2 23.5 24.9 13.8 21.7 28.4
P / FCF 6-point trend, +40.4% · · · · · · 58.1 35.0 36.7 18.2 37.2 41.4
Earnings Yield 12-point trend, +10.0% 4.5% 0.91% 2.0% 2.5% 2.0% 1.6% 2.6% 3.6% 2.7% 4.3% 4.2% 4.1%

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

Estado de resultados
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ingresos $2.94B$2.52B$1.57B$1.02B$958M
Margen Bruto % 65.0%75.0%
Margen Operativo % 16.3%6.6%8.5%17.9%
Beneficio neto $538M$103M$123M$190M$149M
EPS Diluido $3.92$0.75$1.07$1.85$1.44
Balance general
2025-12-312024-12-312023-12-312022-12-312021-12-31
Ratio corriente 4.32.54.96.2
Ratio Rápido 2.50.81.43.0
Flujo de Efectivo
2025-12-312024-12-312023-12-312022-12-312021-12-31
Flujo de caja libre $589M$405M$165M$219M

Señales de trading Señales recientes de compra/venta con precio de entrada y ratio riesgo/recompensa

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos

📊

Elige las métricas que te importan — haz clic en el ➕ junto a cualquier fila en Fundamentales Completos arriba.

Tu selección se guarda y te sigue en todos los tickers.

Propietarios institucionales (13F) 642 declarantes · $5.7B total · A fecha de 30 de junio de 2026

Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.

Actividad institucional — Q2 2026 vs trimestre anterior
Nuevas posiciones Posiciones cerradas Aumentado Disminuido Cambio neto de acciones
82 (-27 vs trimestre anterior) 80 (+30 vs trimestre anterior) 241 (+22 vs trimestre anterior) 176 (-6 vs trimestre anterior) +11.4M

Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.

Institución Valor Acciones % de 13F rastreadas Tipo
VANGUARD CAPITAL MANAGEMENT LLC $403 546 103 5 107 532 7,04% Acciones
VANGUARD PORTFOLIO MANAGEMENT LLC $394 606 359 4 994 385 6,89% Acciones
STATE STREET CORP $293 540 630 3 714 029 5,12% Acciones
Sculptor Capital LP $237 030 000 3 000 000 4,14% Acciones
Burgundy Asset Management Ltd. $212 054 428 3 460 983 3,70% Acciones
ALLIANCEBERNSTEIN L.P. $205 090 439 2 380 344 3,58% Acciones
DIMENSIONAL FUND ADVISORS LP $166 610 599 2 108 728 2,91% Acciones
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $135 630 225 1 716 621 2,37% Acciones
GEODE CAPITAL MANAGEMENT, LLC $134 690 079 1 704 191 2,35% Acciones
Boston Partners $112 054 767 1 418 394 1,96% Acciones
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC $101 519 633 1 284 896 1,77% Acciones
Quantinno Capital Management LP $96 320 933 1 219 098 1,68% Acciones
NORGES BANK $89 048 300 1 127 051 1,55% Acciones
FULLER & THALER ASSET MANAGEMENT, INC. $88 055 393 1 114 484 1,54% Acciones
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC $88 048 981 1 114 403 1,54% Acciones
MANUFACTURERS LIFE INSURANCE COMPANY, THE $84 736 329 1 072 476 1,48% Acciones
GENEVA CAPITAL MANAGEMENT LLC $78 941 870 999 138 1,38% Acciones
Madison Avenue Partners, LP $73 891 416 935 216 1,29% Acciones
Boston Trust Walden Corp $73 637 557 932 003 1,28% Acciones
ANTIPODES PARTNERS Ltd $71 581 796 905 984 1,25% Acciones
Global Alpha Capital Management Ltd. $67 681 230 856 616 1,18% Acciones
Vestal Point Capital, LP $67 158 500 850 000 1,17% Acciones
VANGUARD GROUP INC $59 221 500 678 290 1,03% Acciones
Stephens Investment Management Group LLC $57 159 864 723 451 1,00% Acciones
VANGUARD FIDUCIARY TRUST CO $56 575 822 716 059 0,99% Acciones
Clark Capital Management Group, Inc. $54 271 890 686 899 0,95% Acciones
AMERICAN CAPITAL MANAGEMENT INC $51 599 219 653 072 0,90% Acciones
ANCHOR CAPITAL ADVISORS LLC $51 225 201 648 338 0,89% Acciones
Camber Capital Management LP $47 216 000 800 000 0,82% Acciones
Capital World Investors $46 664 254 590 612 0,81% Acciones
Artemis Investment Management LLP $45 305 914 573 420 0,79% Acciones
Swedbank AB $41 113 881 520 363 0,72% Acciones
OBERWEIS ASSET MANAGEMENT INC/ $40 461 021 512 100 0,71% Acciones
RAYMOND JAMES FINANCIAL INC $39 194 096 496 065 0,68% Acciones
Paradice Investment Management LLC $39 023 513 493 906 0,68% Acciones
Soleus Capital Management, L.P. $37 049 527 468 922 0,65% Acciones
VICTORY CAPITAL MANAGEMENT INC $34 953 155 442 389 0,61% Acciones
ENVESTNET ASSET MANAGEMENT INC $34 559 104 437 402 0,60% Acciones
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ $33 569 453 424 876 0,59% Acciones
FIRST TRUST ADVISORS LP $32 942 568 416 943 0,57% Acciones
FMR LLC $32 503 608 411 386 0,57% Acciones
Grantham, Mayo, Van Otterloo & Co. LLC $32 370 792 409 705 0,56% Acciones
Holocene Advisors, LP $31 598 627 399 932 0,55% Acciones
Pembroke Management, LTD $31 513 929 398 860 0,55% Acciones
GOLDMAN SACHS GROUP INC $31 286 538 395 982 0,55% Acciones
Annex Advisory Services, LLC $30 189 344 350 387 0,53% Acciones
Bares Capital Management, Inc. $29 845 058 521 129 0,52% Acciones
Capital Impact Advisors, LLC $29 246 895 370 167 0,51% Acciones
SIRIOS CAPITAL MANAGEMENT L P $28 050 051 355 019 0,49% Acciones
Bridgewater Associates, LP $27 809 466 351 974 0,49% Acciones
CONGRESS ASSET MANAGEMENT CO $26 754 761 338 625 0,47% Acciones
Terril Brothers, Inc. $25 403 295 321 520 0,44% Acciones
Sio Capital Management, LLC $23 846 482 301 816 0,42% Acciones
SEGALL BRYANT & HAMILL, LLC $23 729 389 300 334 0,41% Acciones
Champlain Investment Partners, LLC $22 982 271 290 878 0,40% Acciones
RHUMBLINE ADVISERS $22 513 223 284 942 0,39% Acciones
Gotham Asset Management, LLC $22 364 413 283 058 0,39% Acciones
UBS Group AG $22 286 430 282 071 0,39% Acciones
KENNEDY CAPITAL MANAGEMENT LLC $22 020 640 278 707 0,38% Acciones
MetLife Investment Management, LLC $21 771 680 275 556 0,38% Acciones
Kathmere Capital Management, LLC $21 450 978 271 497 0,37% Acciones
Retirement Systems of Alabama $20 830 354 263 642 0,36% Acciones
Foresight Group Ltd Liability Partnership $19 759 724 254 030 0,34% Acciones
NICHOLAS COMPANY, INC. $19 699 484 249 329 0,34% Acciones
BANK OF AMERICA CORP /DE/ $19 524 872 247 119 0,34% Acciones
Varenne Capital Partners $18 807 009 238 200 0,33% Acciones
GLENMEDE TRUST CO NA $18 639 881 235 918 0,33% Acciones
Mesirow Institutional Investment Management, Inc. $18 549 041 224 266 0,32% Acciones
California Public Employees Retirement System $18 120 944 229 350 0,32% Acciones
Woodline Partners LP $17 906 826 226 640 0,31% Acciones
Swiss National Bank $17 862 344 226 077 0,31% Acciones
Corient Private Wealth LP $17 322 828 219 248 0,30% Acciones
GABELLI FUNDS LLC $16 671 110 211 000 0,29% Acciones
Lightrock Netherlands B.V. $16 367 000 207 151 0,29% Acciones
Sofinnova Investments, Inc. $15 802 000 200 000 0,28% Opción de compra
RENAISSANCE TECHNOLOGIES LLC $15 558 491 196 918 0,27% Acciones
STATE OF WISCONSIN INVESTMENT BOARD $15 455 225 195 611 0,27% Acciones
LPL Financial LLC $15 233 500 192 805 0,27% Acciones
Susquehanna Portfolio Strategies, LLC $15 165 574 191 945 0,26% Acciones
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $14 032 018 177 598 0,24% Acciones
Leith Wheeler Investment Counsel Ltd. $13 821 540 174 934 0,24% Acciones
BlackRock, Inc. $13 638 706 172 620 0,24% Acciones
AMERICAN CENTURY COMPANIES INC $13 486 770 170 697 0,24% Acciones
WCM INVESTMENT MANAGEMENT, LLC $13 455 918 160 304 0,23% Acciones
Leeward Investments, LLC - MA $12 983 476 164 327 0,23% Acciones
Walleye Capital LLC $12 358 823 156 421 0,22% Acciones
JANUS HENDERSON GROUP PLC $12 232 394 141 973 0,21% Acciones
Bellevue Group AG $11 543 993 146 108 0,20% Acciones
Sterling Investment Advisors, Ltd. $11 379 257 144 023 0,20% Acciones
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $11 223 202 130 260 0,20% Acciones
Defilade Capital Management, L.P. $11 032 719 139 637 0,19% Acciones
PARADIGM CAPITAL MANAGEMENT INC/NY $10 934 984 138 400 0,19% Acciones
Glenmede Investment Management, LP $10 909 935 190 500 0,19% Acciones
BNP PARIBAS FINANCIAL MARKETS $10 809 042 136 806 0,19% Acciones
ALGERT GLOBAL LLC $10 560 477 133 660 0,18% Acciones
GAMCO INVESTORS, INC. ET AL $10 209 435 129 217 0,18% Acciones
ArrowMark Colorado Holdings LLC $9 102 268 115 204 0,16% Acciones
STRS OHIO $8 815 936 111 580 0,15% Acciones
VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. $8 503 609 107 627 0,15% Acciones
VANGUARD ASSET MANAGEMENT, Ltd $8 430 130 106 697 0,15% Acciones

Informantes de la empresa 22 insiders · 11 directivos · 15 consejeros

Insider Rol Última actividad Acciones en propiedad Compras 12m Ventas 12m Neto 12m
Keith W Pfeil President, CEO 21 de enero de 2026 A 0 0 0 $0
Daniel T Scavilla President, CEO 23 de enero de 2025 A 0 0 0 $0
David M Demski President, CEO 27 de enero de 2022 A 0 0 0 $0
Kyle Kline Senior Vice President, CFO 21 de enero de 2026 A 0 0 2 $-2 032 133
Richard A Baron Senior VP and CFO 2 de mayo de 2014 M 0 0 0 $0
Anthony L Williams President 7 de marzo de 2019 M 0 0 0 $0
Kelly Huller EVP, GC, Corporate Secretary 25 de febrero de 2026 M 0 0 3 $-3 441 700
David C Paul Executive Chairman 21 de enero de 2026 A 60 417 0 0 $0
Steven Payne Chief Accounting Officer 1 de febrero de 2019 A 0 0 0 $0
Eric Schwartz Senior VP and General Counsel 25 de junio de 2018 M 0 0 0 $0
Brett A Murphy EVP, International Sales 2 de febrero de 2018 A 35 217 0 0 $0
David D Davidar Consejero 27 de julio de 2026 G 507 675 0 2 $-4 169 000
Ann D Rhoads Consejero 4 de junio de 2026 M 40 384 0 3 $-1 402 600
Dan Wolterman Consejero 21 de enero de 2026 A 24 025 0 0 $0
Leslie V Norwalk Consejero 21 de enero de 2026 A 10 419 0 2 $-557 600
Dan Lemaitre Consejero 21 de enero de 2026 A 0 0 0 $0
John A Deford Consejero 21 de enero de 2026 A 15 578 0 0 $0
Robert Andrew Douglas Consejero 21 de enero de 2026 A 2 005 0 0 $0
Stephen T Zarrilli Consejero 21 de enero de 2026 A 0 0 1 $-2 107 250
James R Tobin Consejero 21 de enero de 2026 A 0 0 0 $0
Kurt Wheeler Consejero 22 de enero de 2019 A 44 319 0 0 $0
Robert Liptak Consejero 22 de enero de 2019 A 26 159 0 0 $0

Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto

Propiedad de ETFs Mantenido por 99 ETFs

El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.

Fondo Ponderación Unidades A fecha de Fuente
FXH · First Trust Exchange-Traded AlphaDE… 2,27% 219 621 NS 30 de abril de 2026 N-PORT
GRPM · Invesco Exchange-Traded Fund Trust 1,93% 118 993 SH 8 de agosto de 2026 Diario
HTEC · EXCHANGE TRADED CONCEPTS TRUST 1,86% 10 979 NS 30 de abril de 2026 N-PORT
BUL · Pacer Funds Trust 1,53% 21 591 NS 30 de abril de 2026 N-PORT
IHI · iShares Trust 1,30% 536 949 SH 8 de agosto de 2026 Diario
LFSC · RBB Fund, Inc. 1,27% 16 258 NS 31 de mayo de 2026 N-PORT
ROBO · EXCHANGE TRADED CONCEPTS TRUST 1,24% 242 837 NS 30 de abril de 2026 N-PORT
DTEC · ALPS ETF Trust 0,87% 7 891 NS 31 de mayo de 2026 N-PORT
TAX · EA Series Trust 0,86% 2 682 NS 29 de mayo de 2026 N-PORT
RFG · Invesco Exchange-Traded Fund Trust 0,86% 37 446 SH 8 de agosto de 2026 Diario
LSEQ · Harbor ETF Trust 0,83% 1 408 NS 30 de abril de 2026 N-PORT
MCOW · Pacer Funds Trust 0,82% 90 NS 30 de abril de 2026 N-PORT
FNY · First Trust Exchange-Traded AlphaDE… 0,55% 31 832 NS 30 de abril de 2026 N-PORT
TMFX · RBB Fund, Inc. 0,54% 2 130 NS 31 de mayo de 2026 N-PORT
CZA · Invesco Exchange-Traded Fund Trust 0,51% 11 913 SH 8 de agosto de 2026 Diario
IJK · iShares Trust 0,49% 662 259 SH 8 de agosto de 2026 Diario
IVOG · VANGUARD ADMIRAL FUNDS 0,47% 111 810 SH 8 de agosto de 2026 Diario
MMSC · First Trust Exchange-Traded Fund VI… 0,39% 2 462 NS 31 de mayo de 2026 N-PORT
JPME · J.P. Morgan Exchange-Traded Fund Tr… 0,38% 18 545 NS 30 de abril de 2026 N-PORT
GQQQ · EA Series Trust 0,34% 5 950 NS 29 de mayo de 2026 N-PORT
BKMC · BNY Mellon ETF Trust 0,31% 21 679 NS 30 de abril de 2026 N-PORT
PTMC · Pacer Funds Trust 0,29% 12 781 NS 30 de abril de 2026 N-PORT
XJH · iShares Trust 0,29% 15 314 SH 8 de agosto de 2026 Diario
ISCG · iShares Trust 0,29% 35 610 SH 8 de agosto de 2026 Diario
FNX · First Trust Exchange-Traded AlphaDE… 0,29% 42 239 NS 30 de abril de 2026 N-PORT
SMDX · Tidal Trust III 0,29% 3 969 NS 30 de abril de 2026 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0,28% 26 195 NS 31 de mayo de 2026 N-PORT
QVMM · Invesco Exchange-Traded Fund Trust … 0,28% 15 001 SH 8 de agosto de 2026 Diario
ANEW · ProShares Trust 0,26% 244 NS 31 de mayo de 2026 N-PORT
IJH · iShares Trust 0,25% 3 909 873 SH 8 de agosto de 2026 Diario
IVOO · VANGUARD ADMIRAL FUNDS 0,25% 183 180 SH 8 de agosto de 2026 Diario
VBK · VANGUARD INDEX FUNDS 0,24% 1 499 816 SH 8 de agosto de 2026 Diario
CLSE · Trust for Professional Managers 0,23% 17 617 NS 31 de mayo de 2026 N-PORT
BFOR · ALPS ETF Trust 0,22% 5 809 NS 31 de mayo de 2026 N-PORT
FSMD · FIDELITY COVINGTON TRUST 0,21% 56 008 NS 30 de abril de 2026 N-PORT
BBMC · J.P. Morgan Exchange-Traded Fund Tr… 0,21% 46 648 NS 30 de abril de 2026 N-PORT
MIDU · Direxion Shares ETF Trust 0,20% 1 845 NS 30 de abril de 2026 N-PORT
MVV · ProShares Trust 0,20% 3 849 NS 31 de mayo de 2026 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0,19% 535 955 NS 31 de mayo de 2026 N-PORT
AFSM · First Trust Exchange-Traded Fund VI… 0,17% 2 091 NS 31 de mayo de 2026 N-PORT
SCHM · SCHWAB STRATEGIC TRUST 0,17% 300 905 NS 31 de mayo de 2026 N-PORT
FAD · First Trust Exchange-Traded AlphaDE… 0,16% 8 751 NS 30 de abril de 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 0,16% 51 771 NS 30 de abril de 2026 N-PORT
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0,16% 7 980 NS 30 de abril de 2026 N-PORT
IYH · iShares Trust 0,15% 67 336 SH 8 de agosto de 2026 Diario
REVS · Columbia ETF Trust I 0,15% 4 563 NS 30 de abril de 2026 N-PORT
ISCB · iShares Trust 0,14% 5 059 SH 8 de agosto de 2026 Diario
UMDD · ProShares Trust 0,14% 538 NS 31 de mayo de 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,13% 338 547 SH 8 de agosto de 2026 Diario
DFAS · Dimensional ETF Trust 0,13% 199 853 NS 30 de abril de 2026 N-PORT